Literature DB >> 2240876

Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation.

D K Henderson1, B J Fahey, M Willy, J M Schmitt, K Carey, D E Koziol, H C Lane, J Fedio, A J Saah.   

Abstract

OBJECTIVES: To summarize the results of a 6-year, ongoing, prospective study of the risk for human immunodeficiency virus type 1 (HIV-1) transmission among health care workers, and to estimate the magnitude of the risk for HIV-1 infection associated with different types of occupational exposures.
DESIGN: Prospective cohort study; the median follow-up for employees sustaining parenteral exposures was 30.2 months (range, 6 to 69 months).
SUBJECTS: Health care workers at the Clinical Center, National Institutes of Health, including those reporting parenteral and nonparenteral occupational exposures to HIV-1.
MEASUREMENTS AND MAIN RESULTS: One thousand three hundred and forty-four clinical health care workers reported 179 percutaneous and 346 mucous membrane exposures to fluids from HIV-1-infected patients during a 6-year period. Responding to a supplementary questionnaire, 559 of these workers reported 2712 cutaneous exposures to blood from HIV-1-infected patients and more than 10,000 cutaneous exposures to blood from all patients during a 12-month period. Occupational transmission of HIV-1 occurred in a single worker after a parenteral exposure to blood from an HIV-1-infected patient. No infections occurred after either mucous membrane or cutaneous exposures to blood from HIV-1-infected patients. Use of newer diagnostic technologies (for example, antigen detection, gene amplification) has not resulted in the identification of occupationally transmitted seronegative infections.
CONCLUSIONS: Combining our results with those of other prospective studies, the risk for HIV-1 transmission associated with a percutaneous exposure to blood from an HIV-1-infected patient is approximately 0.3% per exposure (95% CI, 0.13% to 0.70%); the risks associated with occupational mucous membrane and cutaneous exposures are likely to be substantially smaller. These data support the use of barrier precautions and suggest a need for strategies that change health care providers' attitudes and behaviors.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; National Institutes of Health

Mesh:

Substances:

Year:  1990        PMID: 2240876     DOI: 10.7326/0003-4819-113-10-740

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  55 in total

1.  Surgeons' and occupational health departments' awareness of guidelines on post-exposure prophylaxis for staff exposed to HIV: telephone survey.

Authors:  S E Duff; C K Wong; R E May
Journal:  BMJ       Date:  1999-07-17

2.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 3.  Health and safety at necropsy.

Authors:  J L Burton
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

4.  HIV-seropositive surgeons: informed consent and public health policy.

Authors:  J G Wright; P A Singer
Journal:  CMAJ       Date:  1992-07-01       Impact factor: 8.262

Review 5.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

6.  [Postexposure prevention after occupational exposure to HBV, HCV and HIV].

Authors:  U Sarrazin; R Brodt; C Sarrazin; S Zeuzem
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

Review 7.  Transmission of hepatitis and AIDS: risks for the anaesthetist and the patient.

Authors:  C A Trépanier
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

8.  Surgeons' concern and practices of protection against bloodborne pathogens.

Authors:  J M Patterson; C B Novak; S E Mackinnon; G A Patterson
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

9.  Is there a benefit to a routine preoperative screening of infectivity for HIV, hepatitis B and C virus before elective orthopaedic operations?

Authors:  P Weber; J Eberle; J R Bogner; F Schrimpf; V Jansson; S Huber-Wagner
Journal:  Infection       Date:  2012-12-07       Impact factor: 3.553

10.  What is the dentist's occupational risk of becoming infected with hepatitis B or the human immunodeficiency virus?

Authors:  E I Capilouto; M C Weinstein; D Hemenway; D Cotton
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.